Short‐term NACE · people with coronary artery disease undergoing diagnostic coronary angiography and percutaneous coronary intervention
Transradial probably leads to lower short‐term NACE compared with transfemoral approach (moderate certainty).
1 finding from 1 review
Short‐term cardiac death · people with coronary artery disease undergoing diagnostic coronary angiography and percutaneous coronary intervention
Transradial probably leads to lower short‐term cardiac death compared with transfemoral approach (moderate certainty).
1 finding from 1 review
Short‐term MI · people with coronary artery disease undergoing diagnostic coronary angiography and percutaneous coronary intervention
Transradial showed no clear difference in short‐term MI compared with transfemoral approach (high certainty).
1 finding from 1 review
Success of the procedure · people with coronary artery disease undergoing diagnostic coronary angiography and percutaneous coronary intervention
Transradial probably leads to lower success of the procedure compared with transfemoral approach (moderate certainty).
1 finding from 1 review
Short‐term all‐cause mortality · people with coronary artery disease undergoing diagnostic coronary angiography and percutaneous coronary intervention
Transradial leads to lower short‐term all‐cause mortality compared with transfemoral approach (high certainty).
1 finding from 1 review
Bleeding · people with coronary artery disease undergoing diagnostic coronary angiography and percutaneous coronary intervention
Transradial may leads to lower bleeding compared with transfemoral approach (low certainty).
1 finding from 1 review
Access site complications · people with coronary artery disease undergoing diagnostic coronary angiography and percutaneous coronary intervention
Transradial may leads to lower access site complications compared with transfemoral approach (low certainty).
1 finding from 1 review
All‐cause mortality · people with or without existing CVD, men and women
Higher polyunsaturated fatty acid (PUFA) showed no clear difference in all‐cause mortality compared with lower PUFA (moderate certainty).
1 finding from 1 review
Adiposity · people with or without existing cardiovascular disease, men and women
1 finding from 1 review
Cholesterol mg/dL · people with or without existing cardiovascular disease, men and women
1 finding from 1 review
Serum fasting triglyceride (TG, mmol/L) · people with or without existing cardiovascular disease, men and women
1 finding from 1 review
HDL‐cholesterol · people with or without existing cardiovascular disease, men and women
1 finding from 1 review
Serum low‐density lipoprotein (LDL, mmol/L) · people with or without existing cardiovascular disease, men and women
1 finding from 1 review
CHD events · people with or without existing CVD, men and women
Higher polyunsaturated fatty acid (PUFA) showed no clear difference in coronary heart disease events compared with lower PUFA (moderate certainty).
1 finding from 1 review
Stroke · people with or without existing CVD, men and women
Higher polyunsaturated fatty acid (PUFA) showed no clear difference in stroke compared with lower PUFA (low certainty).
1 finding from 1 review
Major adverse cardiac and cerebrovascular events · people with or without existing CVD, men and women
It is very uncertain whether higher polyunsaturated fatty acid (PUFA) changes major adverse cardiac and cerebrovascular events compared with lower PUFA (very low certainty).
1 finding from 1 review
Cardiovascular mortality · people with or without existing cardiovascular disease, men and women
Higher polyunsaturated fatty acid (PUFA) showed no clear difference in cardiovascular mortality compared with lower PUFA (low certainty).
1 finding from 1 review
Cardiovascular events · people with or without existing cardiovascular disease, men and women
Higher polyunsaturated fatty acid (PUFA) showed no clear difference in cardiovascular events compared with lower PUFA (moderate certainty).
1 finding from 1 review
Coronary heart disease mortality – CHD deaths · people with or without existing cardiovascular disease, men and women
Higher polyunsaturated fatty acid (PUFA) showed no clear difference in coronary heart disease mortality compared with lower PUFA (low certainty).
1 finding from 1 review
Atrial fibrillation and arrhythmias · people with or without existing cardiovascular disease, men and women
It is very uncertain whether higher polyunsaturated fatty acid (PUFA) changes atrial fibrillation and arrhythmias compared with lower PUFA (very low certainty).
1 finding from 1 review